Poland· PL-100252738

Tepadina

A thiotepa product containing thiotepum, registered in Poland by ADIENNE S.r.l. S.U.. The same ATC class is registered in 16 of our 19 countries.

ATC L01AC01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTepadinaATCL01AC01REGISTER NO.PL-100252738PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Thiotepa is registered in 16 of 19 countries.

Countries holding a registration under ATC L01AC01 (thiotepa), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose

Thiotepa · ATC L01AC01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Thiotepum
Manufacturer
ADIENNE S.r.l. S.U.
Country
Poland (PL)
ATC code
L01AC01
ATC class
Thiotepa
Defined daily dose
1.62 g, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990893553
  • gtin
    08051739320138
  • gtin
    08051739320190

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

202 interactions on record for thiotepa.

Graded by severity as the source publishes them — 43 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Thiotepa · interactions on record

202 records

  • 43 severe
  • 105 moderate
  • 14 minor
  • 40 info

Most severe, free to view

  • Nalidixic acidJ01MB02severe
  • CyclophosphamideL01AA01severe
  • ChlorambucilL01AA02severe
  • MelphalanL01AA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Thiotepa in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All thiotepa products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Thiotepa Fresenius Kabi
  • Belgium · Thiotepa Fresenius Kabi
  • Bulgaria · Тиотепа Msn
  • Czechia · Thiotepa Fresenius Kabi, Thiotepa Msn
  • Germany · Thionovia, Thiotepa Fresenius Kabi
  • Denmark · Thiotepa Abcur, Thiotepa Fresenius Kabi
  • Estonia · Thiotepa Fresenius Kabi, Thiotepa Msn
  • Spain · Thionovia, Thiotepa Vivanta
  • Finland · Thiotepa Abcur, Thiotepa Fresenius Kabi
  • France · Thionovia, Thiotepa Fresenius Kabi
  • United Kingdom (Northern Ireland) · Thiotepa, Thiotepa Hikma Farmacêutica (Portugal)
  • Croatia · Tiotepa Fresenius Kabi, Tiotepa Msn
  • Hungary · Thiotepa, Thiotepa Medac
  • Ireland · Thiotepa Fresenius Kabi
  • Iceland · Tepadina, Thiotepa Abcur
  • Italy · Thionovia, Thiotepa Medac
  • Liechtenstein · Tepadina, Thiotepa Riemser
  • Lithuania · Thiotepa Fresenius Kabi, Thiotepa Msn
  • Latvia · Thiotepa Fresenius Kabi, Thiotepa Msn
  • Netherlands · Thiotepa Fresenius Kabi, Thiotepa Medac
  • Norway · Tepadina, Thiotepa Abcur
  • Portugal · Tiotepa Fresenius Kabi, Tiotepa Hikma
  • Romania · Thiotepa Fresenius Kabi, Thiotepa Msn
  • Sweden · Thionovia, Thiotepa Abcur
  • Slovenia · Thiotepa Msn
  • Slovakia · Thiotepa Fresenius Kabi, Thiotepa Msn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a1bb8887-b980-4d16-9ddb-911187b52bc9
GET /v1/drugs/a1bb8887-b980-4d16-9ddb-911187b52bc9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania koncentratu roztworu do infuzji",
  "source": "urpl",
  "strength": "100 mg",
  "packaging": "05909990893553 ¦ Rpz ¦ Skasowane ¦ EU/1/10/622/002 ¦ 68599\n1 fiol.  proszku\n08051739320138 ¦ Rpz ¦ Skasowane ¦ EU/1/10/622/002 ¦ 133657\n1 fiol.  proszku\n08051739320190 ¦ Rpz ¦ EU/1/10/622/002 ¦ 152846\n1 fiol.  proszku",
  "substance": "Thiotepum 100 mg",
  "common_name": "Thiotepum",
  "pl_product_id": "100252738",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about thiotepa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.